1: J Biol Chem. 2003 Jan 24;278(4):2571-80. Epub 2002 Nov 8. 

Regulation of expression of the phospholipid hydroperoxide/sperm nucleus
glutathione peroxidase gene. Tissue-specific expression pattern and
identification of functional cis- and trans-regulatory elements.

Borchert A, Savaskan NE, Kuhn H.

Institute of Biochemistry, Humboldt University Medical School Charite,
Monbijoustrasse 2, 10117 Berlin, Germany.

A sperm nucleus glutathione peroxidase (snGPx), which is closely related to the
phospholipid hydroperoxide glutathione peroxidase (phGPx), was recently
discovered in late spermatids. Both GPx isoforms originate from a joint ph/snGPx
gene, but their N-terminal peptides are encoded by alternative first exons. The
expression of the two enzymes is differentially regulated in various cells, but
little is known about the regulatory mechanisms. To explore the tissue-specific
regulation of expression of the two isoenzymes, we first investigated their
tissue distribution. Whereas phGPx is expressed at low levels in many organs,
snGPx was only detected in testis, kidney, and in the human embryonic kidney
cell line HEK293. Subcellular fractionation studies and immunoelectron
microscopy revealed a cytosolic localization. To explore the mechanistic reasons
for the differential expression pattern, we first tested the activity of the
putative phGPx and snGPx promoters. The 5'-flanking region of the joint ph/snGPx
gene exhibits strong promoter activity. In contrast, the putative snGPx
promoter, which comprises 334 bp of intronic sequences, lacks major promoter
activity. However, it strongly suppresses the activity of the ph/snGPx promoter.
These data suggest negative regulatory elements in the first intron of the
ph/snGPx gene, and DNase protection assays revealed the existence of several
protein-binding sites. The corresponding trans-regulatory proteins (SP1, ERG1,
GATA1, SREBP1, USF1, and CREBP1) were identified, and in vivo binding of EGR1
and SREBP1 was shown by chromatin immunoprecipitation. These data indicate for
the first time somatic expression of the snGPx and provide evidence for the
existence of intronic negative cis-regulatory elements in the ph/snGPx gene. Our
failure to detect an alternative snGPx promoter suggests that transcription of
the ph/snGPx gene may be regulated by a joint basic promoter. The decision,
which GPx isoform is expressed in a given cell, appears to be made by
alternative splicing of a joint primary transcript.

PMID: 12427732 [PubMed - indexed for MEDLINE]


---------------------------------------------------------------


2: Pathol Biol (Paris). 1999 Apr;47(4):358-63. 

[Transcription factors and angiogenesis]

[Article in French]

Soncin F, Fafeur V, Vandenbunder B.

EP 560 CNRS, Institut Pasteur de Lille, Institut de Biologie de Lille, France.

Various strategies led to the identification of transcription factors that take
part to the control of different steps during the formation of new blood
vessels: the description of the expression pattern of genes encoding these
factors during embryonic development for ETS-1, ERG and FLI, SCL/TAL, GATA1 and
2, the description of the phenotype of embryos obtained after gene inactivation
by homologous recombination for ARNT or LKLF, and the study of transcriptional
regulation in cultured endothelial cells for EGR1 or HOX-D3. Altogether, these
results showed that there is no transcription factor specific for endothelial
cells or for one step in the formation of blood vessels. Rather, factors
controlling gene expression induced by hypoxia, shear-stress or growth factors
take part in the morphogenesis of the vascular tree. The study of these factors
may allow to identify potential therapeutic targets for treatments aimed at
inhibiting or stimulating the development of new blood vessels.

Publication Types:
    Review
    Review, Tutorial

PMID: 10372405 [PubMed - indexed for MEDLINE]


---------------------------------------------------------------